Sutter Institute for Medical Research
8 Medical Plaza Drive
Suite 300
Roseville, CA, 95661
9167825106
ChellaR@sutterhealth.org
Primary Research Interests
Related Clinical Trials
Locally Advanced (COAST)
Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC (COAST)
Investigators: Kristin N. Arreola M.D., Deepti Behl MD, Rajeswari Chellappah M.D., Sivakumar Reddy M.D., Vijay Suhag M.D.
Status: Active, Recruiting
Research Studies
Genomic Health Oncotype DX AR-V7
Genomic Health 09-060: A real-world observational study to provide prospective information
on the management of patients with metastatic castration-resistant prostate cancer
(mCRPC) with disease progression after at least one line of androgen receptor-targeted
therapy (ARTT) and the use of the Oncotype DX AR-V7 Nucleus Detect® assay in subsequent
management
Investigators: Kristin N. Arreola M.D., Rajeswari Chellappah M.D., Brian K. Kim M.D, Sivakumar Reddy M.D., Nitin Rohatgi MD, David Yee M.D., MPH